Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNCL002440

Drug Information
NameBAY 80-6946
CompanyBayer HealthCare Pharmaceuticals
IndicationCancer
[ICD9: 140-229   ICD10: C00-C96]
Phase II    
Non-Hodgkin lymphoma
[ICD9: 200, 202   ICD10: C82-C85]
Phase II    
Solid Tumors
[ICD9: 140-199, 210-229   ICD10: C00-C75, C7A, C7B, D10-D36, D3A]
Phase I    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C23H28N8O4/c1-33-19-17(35-10-2-6-30-8-11-34-12-9-30)4-3-16-18(
19)28-23(31-7-5-25-20(16)31)29-21(32)15-13-26-22(24)27-14-15/h3-4
,13-14H,2,5-12H2,1H3,(H2,24,26,27)(H,28,29,32)
InChIKeyPZBCKZWLPGJMAO-UHFFFAOYSA-N
Canonical SMILESCOC1=C(C=CC2=C1N=C(N3C2=NCC3)NC(=O)C4=CN=C(N=C4)N)OCCCN5CCOCC5    
FormulaC23H28N8O4
PubChem Compound IDCID 24989044.
TargetPI3K



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543